Product NDC: | 57664-118 |
Proprietary Name: | VERAPAMIL HYDROCHLORIDE |
Non Proprietary Name: | VERAPAMIL HYDROCHLORIDE |
Active Ingredient(s): | 240 mg/1 & nbsp; VERAPAMIL HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57664-118 |
Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090529 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120101 |
Package NDC: | 57664-118-13 |
Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (57664-118-13) |
NDC Code | 57664-118-13 |
Proprietary Name | VERAPAMIL HYDROCHLORIDE |
Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (57664-118-13) |
Product NDC | 57664-118 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | VERAPAMIL HYDROCHLORIDE |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120101 |
Marketing Category Name | ANDA |
Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Strength Number | 240 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |